The Molecular Biology of Memory Storage: a Dialogue Between Genes and Synapses
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Unrestricted Immigration and the Foreign Dominance Of
Unrestricted Immigration and the Foreign Dominance of United States Nobel Prize Winners in Science: Irrefutable Data and Exemplary Family Narratives—Backup Data and Information Andrew A. Beveridge, Queens and Graduate Center CUNY and Social Explorer, Inc. Lynn Caporale, Strategic Scientific Advisor and Author The following slides were presented at the recent meeting of the American Association for the Advancement of Science. This project and paper is an outgrowth of that session, and will combine qualitative data on Nobel Prize Winners family histories along with analyses of the pattern of Nobel Winners. The first set of slides show some of the patterns so far found, and will be augmented for the formal paper. The second set of slides shows some examples of the Nobel families. The authors a developing a systematic data base of Nobel Winners (mainly US), their careers and their family histories. This turned out to be much more challenging than expected, since many winners do not emphasize their family origins in their own biographies or autobiographies or other commentary. Dr. Caporale has reached out to some laureates or their families to elicit that information. We plan to systematically compare the laureates to the population in the US at large, including immigrants and non‐immigrants at various periods. Outline of Presentation • A preliminary examination of the 609 Nobel Prize Winners, 291 of whom were at an American Institution when they received the Nobel in physics, chemistry or physiology and medicine • Will look at patterns of -
MED C-LIVE Transcript
JUNE 2020 Mario Capecchi, Ph.D. NOT FOR PUBLIC DISTRIBUTION Michael Keel My name is Michael Keel from New Jersey. And it is my honor to introduce Dr. Mario Capecchi. Dr. Capecchi is the Distinguished Professor of Human Genetics at the University of Utah School of Medicine. He is best known for his groundbreaking work in gene targeting, in mass embryo derived stem cells. He was awarded the Nobel Prize in Physiology for Medicine, for his work in finding ways to manipulate the mammalian genome by changing mammals’ genes. His research interests include analysis of neural development in mammals, gene therapy, and production of murine models of human genetic diseases, from cancer to neuropsychiatric disorders. Dr. Capecchi, welcome to the Congress of Future Medical Leaders. Dr. Capecchi Thank you. First of all, welcome to the Medical Leaders’ Congress. It's a pleasure to be here. My name is Mario. I'm going to be talking about gene targeting. Next slide please. My laboratory has developed a technology called gene targeting that allows you to change any gene in any conceivable manner in a living creature, such as a mouse. Next slide. Why do we do gene targeting? Next slide. There are many reasons, but they boil down to two. One is basic research and the other is applied research. In basic research, you investigate the biology of an animal. For example, how do you make a limb or a heart or a brain? Those are basic research questions. The other is applied research. That is we can use gene targeting to generate mice with human diseases. -
2004 Albert Lasker Nomination Form
albert and mary lasker foundation 110 East 42nd Street Suite 1300 New York, ny 10017 November 3, 2003 tel 212 286-0222 fax 212 286-0924 Greetings: www.laskerfoundation.org james w. fordyce On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination Chairman neen hunt, ed.d. for the 2004 Albert Lasker Medical Research Awards. President mrs. anne b. fordyce The Awards will be offered in three categories: Basic Medical Research, Clinical Medical Vice President Research, and Special Achievement in Medical Science. This is the 59th year of these christopher w. brody Treasurer awards. Since the program was first established in 1944, 68 Lasker Laureates have later w. michael brown Secretary won Nobel Prizes. Additional information on previous Lasker Laureates can be found jordan u. gutterman, m.d. online at our web site http://www.laskerfoundation.org. Representative Albert Lasker Medical Research Awards Program Nominations that have been made in previous years may be updated and resubmitted in purnell w. choppin, m.d. accordance with the instructions on page 2 of this nomination booklet. daniel e. koshland, jr., ph.d. mrs. william mccormick blair, jr. the honorable mark o. hatfied Nominations should be received by the Foundation no later than February 2, 2004. Directors Emeritus A distinguished panel of jurors will select the scientists to be honored. The 2004 Albert Lasker Medical Research Awards will be presented at a luncheon ceremony given by the Foundation in New York City on Friday, October 1, 2004. Sincerely, Joseph L. Goldstein, M.D. Chairman, Awards Jury Albert Lasker Medical Research Awards ALBERT LASKER MEDICAL2004 RESEARCH AWARDS PURPOSE AND DESCRIPTION OF THE AWARDS The major purpose of these Awards is to recognize and honor individuals who have made signifi- cant contributions in basic or clinical research in diseases that are the main cause of death and disability. -
Eighty Years of Fighting Against Cancer in Serbia Ovarian Cancer Vaccine
News Eighty years of fighting against cancer Recent study by Kunle Odunsi et al., Roswell Park Cancer Institute, Buffalo, in Serbia New York, USA, showed an effects of vaccine based on NY-ESO-1, a „cancer This year on December 10th, Serbian society for the fight against cancer has testis“ antigen in preventing the recurrence of ovarian cancer. NY-ESO-1 is a ovarian celebrated the great jubilee - 80 years of its foundation. The celebration took „cancer-testis“ antigen expressed in epithelial cancer (EOC) and is place in Crystal Room of Belgrade’s Hyatt hotel, gathering many distinguished among the most immunogenic tumor antigens defined to date. presence + guests from the country and abroad. This remarkable event has been held Author’s previous study point to the role of of intraepithelial CD8 - under the auspices of the President of Republic of Serbia, Mr. Boris Tadić. infiltrating T lymphocytes in tumors that was associated with improved survival of The whole ceremony was presided by Prof. Dr. Slobodan Čikarić, actual presi- patients with the disease. The NY-ESO-1 peptide epitope, ESO157–170, is recog- + + dent of Society, who greeted guests and wished them a warm welcome. Than nized by HLA-DP4-restricted CD4 T cells and HLA-A2- and A24-restricted CD8 + followed the speech of Serbian health minister, Prof. Dr. Tomica Milosavljević T cells. To test whether providing cognate helper CD4 T cells would enhance who pointed out the importance of preventive measures and public education the antitumor immune response, Odunsi et al., conducted a phase I clinical trial along with timely diagnosis and multidisciplinary treatment in global fight of immunization with ESO157–170 mixed with incomplete Freund's adjuvant + against cancer in Serbia. -
I. Hox Genes 2
School ofMedicine Oregon Health Sciences University CERTIFICATE OF APPROVAL This is certify that the Ph.D. thesis of WendyKnosp has been approved Mentor/ Advisor ~ Member Member QUANTITATIVE ANALYSIS OF HOXA13 FUNCTION IN THE DEVELOPING LIMB By Wendy M. lt<nosp A DISSERTATION Presented to the Department of Molecular and Medical Genetics and the Oregon Health & Science University School of Medicine in partial fulfillment of the requirements for the degree of Doctor of Philosophy August 2006 TABLE OF CONTENTS LIST OF FIGURES iv LIST OF ABBREVIATIONS vii ACKNOWLEDGEMENTS X ABSTRACT xii CHAPTER 1: Introduction 1 I. Hox genes 2 A. Discovery of Hox genes in Drosophila melanogaster 2 B. Hox cluster colinearity and conservation 7 C. Human Hox mutations 9 D. Hoxa13: HFGS and Guttmacher syndromes 10 II. The Homeodomain 12 A. Homeodomain structure 12 B. DNA binding 14 Ill. Limb development 16 A. Patterning of the limb axes 16 B. Digit formation 20 C. lnterdigital programmed cell death 21 IV. BMPs and limb development 23 A. BMP signaling in the limb 23 B. BMP target genes 27 V. Hoxa13 and embryonic development 30 A. The Hoxa13-GFP mouse model 30 B. Hoxa13 mutant phenotypes 34 C. HOXA 13 homeodomain 35 D. HOXA 13 protein-protein interactions 36 E. HOXA 13 target genes 37 VI. Hypothesis and Rationale 39 CHAPTER 2: HOXA13 regulates Bmp2 and Bmp7 40 I. Abstract 42 II. Introduction 43 Ill. Results 46 IV. Discussion 69 v. Materials and Methods 75 VI. Acknowledgements 83 11 CHAPTER 3: Quantitative analysis of HOXA13 function 84 HOXA 13 regulation of Sostdc1 I. -
October 2, 2001, NIH Record, Vol. LIII, No. 20
R Still The Second Best Thing About Payday Translating the Histone Code: A H G H L 1,G H T, S Tale of Tails at Stetten Talk Attacks on U.S. Change Life at NIH By Rich McManus By Alison Davis Security Beefed Up News stories appearing over the last year he transition from peacetime's reliable routine to wartime On Campus would have everyone believe that scientists anxiety took place in only minutes as NTH employees came have-once and for all~racked the human Tto work on an otherwise spectacular late summer morning genetic code. Indeed, two teams of 50th Anniversary Sept. 11 and scientists have already published a draft For NINOS, NIMH discovered by 9:45- sequence of our 3-billion-unit jumble of via office televisions, DNA "letters." But t he task of thoroughly radio, the web, deciphering the code's protein-making phone calls and Grantees Win hallway conversa instructions-something our bodies do Lasker Award SEE STETTEN LECTURE, PAGE 2 tions-that terror ism on an almost unimaginable scale Kolb To Give was taking place in Pittman Lecture New York City and in the heart of Washington, D.C. Fall Computer The workday froze Courses Offered as workers tuned in to the news-the World Trade Center towers in flames, Flag flies at half-mast in tragedy's wake. Outdoor Film and smoke rising from behind the Old Executive Office buiJding Dr. C. David Allis to give Stetten Lecture. Festival a Big Hit near the White House. Summer Jobs into Permanent Posts In the OD Office of Communications and Public Liaison in Bldg. -
Neural and Behavioral Science
Sep 21 Molecular mechanisms and behavioral roles for long-term synaptic depression in normal physiology and disease Russell Nicholls Associate Research Scientist, Department of Neuroscience Columbia University Neural Sep 28 Co-existence of lateral and cotuned inhibitory configurations in cortical networks Alex D. Reyes and Behavioral Associate Professor, Center for Neural Science New York University Science Oct 19 Reinforcement learning: beyond reinforcement Nathanial Daw Assistant Professor of Neural Science and Psychology, Center for Neural Science and Center for Brain Imaging New York University SEMINAR SERIES Nov 2 Molecular dissection of amygdala-hippocampal circuitry 2011-2012 Gleb Shumyatsky Associate Professor, Department of Genetics Rutgers University Nov 30 Integrating synaptic plasticity into local and global hippocampal circuits Steven Siegelbaum School of Chair of Neuroscience and Professor of Pharmacology, Howard Hughes Medical Institute Graduate Studies Department of Neuroscience Columbia University SUNY Downstate Medical Center Dec 14 Designing "Intelligent" Neuroprosthetics: Harnessing Multiscale Activity from Systems of Neurons Justin C. Sanchez 450 Clarkson Avenue Associate Professor, Department of Biomedical Engineering Brooklyn, NY 11203-2098 Director of the Neuroprosthetics Research Group University of Miami Jan 11 Dendritic spines and linear networks Rafael Yuste Professor, Department of Biological Sciences Howard Hughes Medical Institute Columbia University Jan 25 The origin of time (in the songbird motor pathway) -
Memory Retrieval and the Passage of Time: from Reconsolidation and Strengthening to Extinction
The Journal of Neuroscience, February 2, 2011 • 31(5):1635–1643 • 1635 Behavioral/Systems/Cognitive Memory Retrieval and the Passage of Time: From Reconsolidation and Strengthening to Extinction Maria Carmen Inda,1 Elizaveta V. Muravieva,1 and Cristina M. Alberini1,2 Departments of 1Neuroscience and 2Psychiatry, Mount Sinai School of Medicine, New York, New York, 10029 An established memory can be made transiently labile if retrieved or reactivated. Over time, it becomes again resistant to disruption and this process that renders the memory stable is termed reconsolidation. The reasons why a memory becomes labile after retrieval and reconsolidates still remains debated. Here, using inhibitory avoidance learning in rats, we provide evidence that retrievals of a young memory, which are accompanied by its reconsolidation, result in memory strengthening and contribute to its overall consolidation. This function associated to reconsolidation is temporally limited. With the passage of time, the stored memory undergoes important changes, as revealed by the behavioral outcomes of its retrieval. Over time, without explicit retrievals, memory first strengthens and becomes refractory to both retrieval-dependent interference and strengthening. At later times, the same retrievals that lead to reconsolidation of a young memory extinguish an older memory. We conclude that the storage of information is very dynamic and that its temporal evolution regulates behavioral outcomes. These results are important for potential clinical applications. Introduction reconsolidation (Nader et al., 2000; Sara, 2000a). This post- A newly formed memory is initially labile and can be disrupted by retrieval lability has been found with numerous memory tasks a variety of interferences, including inhibition of new protein and in different species, although in some conditions it was not synthesis, gene expression, and inactivation of brain regions observed (Dawson and McGaugh, 1969; Tronson and Taylor, (Davis and Squire, 1984; Dudai and Eisenberg, 2004). -
The Nobel Prize in Physiology Or Medicine 2007
PRESS RELEASE 2007-10-08 The Nobel Assembly at Karolinska Institutet has today decided to award The Nobel Prize in Physiology or Medicine 2007 jointly to Mario R. Capecchi, Martin J. Evans and Oliver Smithies for their discoveries of “principles for introducing specific gene modifications in mice by the use of embryonic stem cells” SUMMARY This year’s Nobel Laureates have made a series of ground-breaking discoveries concerning embryonic stem cells and DNA recombination in mammals. Their discoveries led to the creation of an immensely powerful technology referred to as gene targeting in mice. It is now being applied to virtually all areas of biomedicine – from basic research to the development of new therapies. Gene targeting is often used to inactivate single genes. Such gene “knockout” experiments have elucidated the roles of numerous genes in embryonic development, adult physiology, aging and disease. To date, more than ten thousand mouse genes (approximately half of the genes in the mammalian genome) have been knocked out. Ongoing international efforts will make “knockout mice” for all genes available within the near future. With gene targeting it is now possible to produce almost any type of DNA modification in the mouse genome, allowing scientists to establish the roles of individual genes in health and disease. Gene targeting has already produced more than five hundred different mouse models of human disorders, including cardiovascular and neuro-degenerative diseases, diabetes and cancer. Modification of genes by homologous recombination Information about the development and function of our bodies throughout life is carried within the DNA. Our DNA is packaged in chromosomes, which occur in pairs – one inherited from the father and one from the mother. -
ILAE Historical Wall02.Indd 10 6/12/09 12:04:44 PM
2000–2009 2001 2002 2003 2005 2006 2007 2008 Tim Hunt Robert Horvitz Sir Peter Mansfi eld Barry Marshall Craig Mello Oliver Smithies Luc Montagnier 2000 2000 2001 2002 2004 2005 2007 2008 Arvid Carlsson Eric Kandel Sir Paul Nurse John Sulston Richard Axel Robin Warren Mario Capecchi Harald zur Hauser Nobel Prizes 2000000 2001001 2002002 2003003 200404 2006006 2007007 2008008 Paul Greengard Leland Hartwell Sydney Brenner Paul Lauterbur Linda Buck Andrew Fire Sir Martin Evans Françoise Barré-Sinoussi in Medicine and Physiology 2000 1st Congress of the Latin American Region – in Santiago 2005 ILAE archives moved to Zurich to become publicly available 2000 Zonismide licensed for epilepsy in the US and indexed 2001 Epilepsia changes publishers – to Blackwell 2005 26th International Epilepsy Congress – 2001 Epilepsia introduces on–line submission and reviewing in Paris with 5060 delegates 2001 24th International Epilepsy Congress – in Buenos Aires 2005 Bangladesh, China, Costa Rica, Cyprus, Kazakhstan, Nicaragua, Pakistan, 2001 Launch of phase 2 of the Global Campaign Against Epilepsy Singapore and the United Arab Emirates join the ILAE in Geneva 2005 Epilepsy Atlas published under the auspices of the Global 2001 Albania, Armenia, Arzerbaijan, Estonia, Honduras, Jamaica, Campaign Against Epilepsy Kyrgyzstan, Iraq, Lebanon, Malta, Malaysia, Nepal , Paraguay, Philippines, Qatar, Senegal, Syria, South Korea and Zimbabwe 2006 1st regional vice–president is elected – from the Asian and join the ILAE, making a total of 81 chapters Oceanian Region -
2014 Neuroscience Seminars
Tom Clandinin, Ph.D., Stanford University 01/07/14 Dissecting the Circuit Mechanisms of Motion Detection" Host: Helmut Kramer, Ph.D. Lisa Stowers, Ph.D. 02/11/14 "Leveraging Olfaction to Study Emotional Behavior" Host: Julian Meeks, Ph.D. Franck Polleaux, Ph.D, Columbia University 02/18/14 "SRGAP2 and Its Human-Specific Paralogs Coordinate Excitatory and Inhibitory Synaptic Maturation" Host: Genevieve Konopka, Ph.D. Joshua Trachtenberg, Ph.D., UCLA 03/11/14 “Tired of the same old cortical circuitry? Just relax your inhibitions and watch it change!” Host: Jay Gibson, Ph.D. Claudio Grosman, Ph.D., University of Illinois at Urbana-Champaign 03/18/14 “Side-chain conformational flexibility and its impact on ion conduction through channels.” Host: Ryan Hibbs, Ph.D. Cristina Alberini, Ph.D., New York University 03/25/14 “Molecular Mechanisms of Memory Consolidation and Enhancement.” Host, Taekyung Kim, Ph.D. Mustafa Sahin, M.D., Ph.D., Boston's Children's Hospital 04/08/14 “Neuronal Connectivity in Tuberous Sclerosis.” Host: Joe Takahashi, Ph.D. Lu Chen, Ph.D. 04/15/14 “The new face an old molecule: synaptic signaling of retinoic acid.” Host: Ege Kavalali, Ph.D. David Julius, Ph.D. 04/28/14 2014 Neuroscience Retreat Misha B. Ahrens, Ph.D., HHMI, Janelia Research Campus 05/06/14 “Whole-brain exploration of neuronal activity underlying behavior in zebrafish.” Host: Joe Takahashi, Ph.D. Gordon, M.G. Shepherd, M.D., Ph.D., Northwestern University 05/20/14 “Synaptic circuit organization of mouse motor cortex.” Host: Jay Gibson, Ph.D. Uel Jackson McMahan, Ph.D., Texas A&M University 05/27/14 “Imaging Macromolecules that Regulate Synaptic Transmission.” Host: Weichun Lin, Ph.D. -
Lasker Interactive Research Nom'18.Indd
THE 2018 LASKER MEDICAL RESEARCH AWARDS Nomination Packet albert and mary lasker foundation November 1, 2017 Greetings: On behalf of the Albert and Mary Lasker Foundation, I invite you to submit a nomination for the 2018 Lasker Medical Research Awards. Since 1945, the Lasker Awards have recognized the contributions of scientists, physicians, and public citizens who have made major advances in the understanding, diagnosis, treatment, cure, and prevention of disease. The Medical Research Awards will be offered in three categories in 2018: Basic Research, Clinical Research, and Special Achievement. The Lasker Foundation seeks nominations of outstanding scientists; nominations of women and minorities are encouraged. Nominations that have been made in previous years are not automatically reconsidered. Please see the Nomination Requirements section of this booklet for instructions on updating and resubmitting a nomination. The Foundation accepts electronic submissions. For information on submitting an electronic nomination, please visit www.laskerfoundation.org. Lasker Awards often presage future recognition of the Nobel committee, and they have become known popularly as “America’s Nobels.” Eighty-seven Lasker laureates have received the Nobel Prize, including 40 in the last three decades. Additional information on the Awards Program and on Lasker laureates can be found on our website, www.laskerfoundation.org. A distinguished panel of jurors will select the scientists to be honored with Lasker Medical Research Awards. The 2018 Awards will